Author： Fresko Izzet Yazici Hasan
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.18, 2008-12, pp. : 3211-3219
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment-free remission with alemtuzumab in Behçet's disease
Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. :
Access to resources
Recommend
Treatment strategies in Alzheimer's disease
By Levy R.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Behçet's Disease as an Autoinflammatory Disorder
Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. :
Antisense strategies for the treatment of neurological disease
By Stoessl A.J.
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. :